Plain-English translation of NCT01351545 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether cord blood transplants — a procedure using blood cells collected from newborns and frozen for later use — can help treat serious blood cancers and blood disorders. The study is looking at cord blood units that have not been approved by the FDA yet, but are being made available to patients who need them. Researchers want to understand how well these transplants work and how safe they are.
Some patients with blood cancers or inherited blood disorders may benefit from a transplant, but there aren't always enough FDA-approved cord blood units available. This trial exists to make unlicensed cord blood units accessible to patients who need them urgently, while carefully tracking how well the treatment works and whether it's safe.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive a cord blood transplant as your medical treatment — this is not an experimental drug study, but rather a program that makes unlicensed cord blood units available while carefully monitoring your health. After your transplant, researchers will track your recovery, including whether your blood cells return to healthy levels, whether you develop any infections or side effects, and how well you are doing one year after the procedure. You will have regular medical visits and blood tests as part of your standard transplant care.
AI-generated summary from trial data · Jul 8, 2026 · Not medical advice
United States